Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-17T16:57:12.028Z Has data issue: false hasContentIssue false

Surveillance of Antibiotic Resistance: Learning to Live With Bias

Published online by Cambridge University Press:  02 January 2015

Robert Gaynes*
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Hospital Infections Program, National Center for Infectious Diseases, Mailstop E-55, 1600 Clifton Rd NE, Centers for Disease Control and Prevention, Atlanta, GA 30333
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1995

References

1.Cetron, MS, Jernigan, DB, Breiman, RF. Action plan for drug-resistant Streptococcus pneumoniae. Emerging Infectious Diseases 1995;1:6465.Google Scholar
2.Centers for Disease Control and Prevention: Drug-resistant Streptococcus pneumoniae—Kentucky and Tennessee, 1993. MMWR 1994;43:2325.Google Scholar
3.Hofman, J, Cetron, MS, Farley, MM, et al.The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481486.Google Scholar
4.Gorwitz, RJ, Nakashima, AK, Moran, JS, Knapp, JS. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae—United States, 1988-1991. MMWR 1993;42(SS-3):2939.Google Scholar
5.Emori, TG, Gaynes, RP. An overview of nosocomial infections including the role for the microbiology laboratory. Clin Microbiol Rev 1993;6:428442.Google Scholar
6.Lee, LA, Puhr, ND, Maloney, EK, et al.Increase in antimicrobial resistant-Salmonella infections in the United States, 1989-1990. J Infect Dis 1994;170:128134.Google Scholar
7.Ries, AR, Wells, JG, Olibola, A. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention. J Infect Dis 1994;169:10351041.Google Scholar
8.Centers for Disease Control. CDC Surveillance Update. Atlanta, GA: CDC; 01, 1988.Google Scholar
9.Lorian, V. The need for sur veillance for antimicrobial resistance. Infect Control Hosp Epidemiol 1995;16:638641.Google Scholar
10.Atkinson, BA, Lorian, V. Antimicrobial agent susceptibility patterns in bacteria in hospitals from 1971-1982. J Clin Microbiol 1984;20:791796.Google Scholar
11.Centers for Disease Control. Guidelines for evaluating surveillance systems. MMWR 1988;37(S-5):117.Google Scholar
12.Gaynes, R, Culver, D, the National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1991;13:1014.Google Scholar
13.Panlilio, A, Culver, DH, Gaynes, RP, et al.Methicillin-resistant Staphylococcus aureus in the United States, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582586.Google Scholar
14.Gaynes, RP, Culver, DH, the National Nosocomial Infections Surveillance System. Temporal trends in methicillin-resistant Staphylococcus aureus in the United States. Infect Dis Clin Practice 1993;2:452455.Google Scholar
15.Burwen, DR, Banerjee, SN, Gaynes, RP, the National Nosocomial Infections Sur veillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 1994;170:1622–5.Google Scholar
16.Coronado, V, Gaynes, R, Edwards, J, the National Nosocomial Infections Sur veillance System. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16:7175.Google Scholar
17.Monnet, D, Edwards, J, Gaynes, R. Extended spectrum β-lactam-resistant Klebsiella pneumoniae: epidemiologic evidence of interhospital transmission. Infect Control Hosp Epidemiol 1994;15:23. Abstract #24.Google Scholar
18.Langmuir, AD. The surveillance of communicable diseases of national importance. N Engl J Med 1963;268:182192.Google Scholar